Novo Nordisk (NVO) teased some new details about a potential Ozempic successor during a call with investors Tuesday.

The drug semaglutide is already proving incredibly effective in tackling diabetes (under the brand name Ozempic) and weight ...

Ozempic (semaglutide) may impact kidney health in certain people, especially those with diabetes. Learn more about what the ...

The ‘Ozempic drug,’ semaglutide, has been found to reduce moderately severe pain caused by knee osteoarthritis and improve ...

You can’t go far lately without seeing news and social media coverage of GLP-1 (glucagon-like peptide-1) receptor agonists ...

People who received weekly injections of semaglutide -- the active agent in the diabetes drug Ozempic and the weight-loss ...

Excitement is building around a new weight loss drug, CagriSema, which is expected to surpass the effects of popular drugs ...

The "Today" host underwent gastric bypass surgery in 2002 to help him lose weight.

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...

The results of a clinical trial published this week found that the active ingredient in the diabetes and weight loss ...